Gregg C. Shepard

A phase II trial of bevacizumab and everolimus as treatment for patients with refractory, progressive intracranial meningioma

Kent C. Shih, Sajeel Chowdhary, Paul Rosenblatt et al. · Journal of Neuro-Oncology · 2016 · 125 citations

Medicine, Neurology, Oncology +4

Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab/everolimus as first-line treatment for patients with glioblastoma.

John D. Hainsworth, Kent C. Shih, Gregg C. Shepard et al. · PubMed · 2012 · 84 citations

Medicine, Oncology, Pharmacotherapy +16

A Phase II Study with Lead-In Safety Cohort of 5-Fluorouracil, Oxaliplatin, and Lapatinib in Combination with Radiation Therapy as Neoadjuvant Treatment for Patients with Localized HER2-Positive Esophagogastric Adenocarcinomas

Gregg C. Shepard, Edward Arrowsmith, Patrick Murphy et al. · The Oncologist · 2017 · 14 citations · Full text

Medicine, Oncology, Radiation Oncology +17